Adamas Pharmaceuticals
ADMS
#7168
Rank
C$0.53 B
Marketcap
$11.63
Share price
0.00%
Change (1 day)
17,103.54%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -C$48.83 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are C$88.18 Million. In 2020 the company made an earning of -C$62.08 Million, an increase over its 2019 earnings that were of -C$0.13 Billion.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$48.83 Million-21.35%
2020-C$62.08 Million-51.34%
2019-C$0.13 Billion-19.45%
2018-C$0.16 Billion28.96%
2017-C$0.13 Billion42.3%
2016-C$86.31 Million6.18%
2015-C$81.29 Million-410.24%
2014C$26.2 M-67.53%
2013C$80.69 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.31 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.25 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
C$6.21 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$30.01 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA